What Doctors Are Learning From Autopsy Findings of Coronavirus (COVID-19) Patients, by Dr. Mike Hansen

Posted on May 7, 2020 | 4 Comments

This entry was posted in Medicine, Science and tagged . Bookmark the permalink.

4 responses to “What Doctors Are Learning From Autopsy Findings of Coronavirus (COVID-19) Patients, by Dr. Mike Hansen”

  1. Neil M. Dunn's avatar Neil M. Dunn | May 7, 2020 at 9:34 pm | Reply

    The arterial thrombus(clot) formation as part of the Antiphospholipid Syndrome (APS) intrigued me so I googled “Prophylaxis therapy for APS clotting disorder” and got the below title of an article abstract.
    “Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.”
    https://www.ncbi.nlm.nih.gov/pubmed/28764618

    I am certainly no expert in coagulation or APS or the use of hydroxchloroquine(HCQ), but that HCQ is recommended by many (either with or without Zinc) to treat COVID-19 and then to find that HCQ may be the drug of choice (according to one abstract) is just more than ironic to me. I wonder about Remdesivir, the NIH drug.

    • Robert Gore's avatar Robert Gore | May 8, 2020 at 4:59 am | Reply

      Gilead has developed Remdesivir. It appears that Gilead is the government’s fair-haired boy among the drug companies, dating back to at least when Donald Rumsfeld was its Chairman of the Board and perhaps earlier.

  2. Realist's avatar Realist | May 8, 2020 at 6:03 am | Reply

    It is quite possible that the patients described had comorbidity prior to Covid-19 and it has nothing to do with Covid-19.
    Poor analysis.

  3. Neil M. Dunn's avatar Neil M. Dunn | May 8, 2020 at 6:48 pm | Reply

    ACSH comments negatively on the fact that Remdesivir can only be given by IV infusion-namely, that it can not probably be used for early treatment of a COVID-19 infection.
    https://www.acsh.org/news/2020/05/07/we-need-remdesivir-pill-badly-14770  

Leave a Reply